<DOC>
	<DOCNO>NCT03032354</DOCNO>
	<brief_summary>They major genus bacteria make colon flora human , constitute intestinal microbial homeostasis , inhibit growth pathogen , improve gut mucosal barrier modulate local systemic immune response . Changes gut microbiota influence immune system increase gut permeability , intestinal inflammation , impaired oral tolerance type 1 diabetes.Taken together , data imply bacteriotherapy may potentially used tool modulate immune system prevent islet destruction . Supplementation Lactobacillus rhamnosus GG Bifidobacterium lactis BB12 improve blood glucose control normoglycaemic pregnant woman reduce frequency gestational diabetes mellitus Aim study : The effect Lactobacillus rhamnosus GG Bifidobacterium lactis BB12 beta-cell function child newly diagnose type 1 diabetes : randomize , double blind , placebo-controlled trial . Primary end point : Area curve ( AUC ) c-peptide level fast 30,60,90,120 min follow start meal Intervention : Included patient randomly assign receive combination Lactobacillus rhamnosus GG Bifidobacterium lactis BB12 ( Probiotics Group ) placebo ( Placebo Group ) six month . The expected result : Beneficial effect Lactobacillus rhamnosus GG Bifidobacterium lactis BB12 beta-cell function show properly perform , methodologically accurate study would create rationale routine use patient newly diagnose type 1 diabetes .</brief_summary>
	<brief_title>Probiotics Newly Recognized Type 1 Diabetes</brief_title>
	<detailed_description>Intervention : At 6-month follow-up visit evaluate adherence occurrence side effect study procedure . The outcome measure assess begin study , 6 12-month follow-up visit .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Type 1 diabetes confirm clinical history presence least one positive autoantibody : antiglutamic acid decarboxylase ( antiGAD ) , islet antigen 2 ( IA2 ) , islet cell antibody ( ICA ) Fasting cpeptide level &gt; /= 0.4 ng/ml The diagnosis diabetes last 60 day Consent participate study Antibiotictherapy last 4 week Taking probiotic last 2 week Intestinal infection last 2 week Intestinal chronic disease</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>probiotic</keyword>
	<keyword>child</keyword>
	<keyword>remission</keyword>
</DOC>